Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FZ9G5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,291
Award facts
- Contract value 100% obligated
- $9,290.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,290.83 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets (30-count packaging) under a firm fixed price contract. This non-set-aside delivery order, awarded on June 2, 2025, with completion scheduled for June 3, 2025, will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child contract under the company's broader pharmaceutical supply relationships with DLA.
This delivery order represents a discrete transaction within AmerisourceBergen Drug Corp's extensive portfolio of federal medical supply contracts with the Defense Logistics Agency. The company maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. REXULTI (brexpiprazole), an atypical antipsychotic medication used in treating major depressive disorder and schizophrenia, exemplifies the specialty pharmaceutical products the distributor routinely supplies to support Department of Defense healthcare systems and federal medical requirements.
Quick answers
Who was awarded contract SPE2DB25FZ9G5?
SPE2DB25FZ9G5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FZ9G5 worth?
The government has obligated $9,291 on SPE2DB25FZ9G5.
Is contract SPE2DB25FZ9G5 an order under another contract?
Yes. SPE2DB25FZ9G5 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FZ9G5 competed?
The extent of competition for SPE2DB25FZ9G5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award